We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Jack in the Box Stock Gains on Alternative Strategic Plan
Read MoreHide Full Article
Jack in the Box Inc. (JACK - Free Report) announced that it is exploring a range of strategic and financing alternatives. This hamburger restaurant chain, with more than 2,000 restaurants, is looking for options that may include the sale of the company. Following the news, the company’s shares gained 2.1% on Dec 17. However, the company’s shares have declined 19.2% in a year’s time, against the industry’s growth of 7.8%.
Nevertheless, the company further added that it has not set any deadline for the completion of this process. Although there is no certainty about any potential deal, the company has started to look for potential buyers. Notably, Jack in the Box sold its subsidiary Qdoba to Apollo Global Management (APO - Free Report) in March 2018.
The Zacks Rank #5 (Strong Sell) company has been bearing the brunt of declining sales for quite some time now. Despite selling its Qdoba subsidiary, the company failed to overcome the hurdles of soft comps and operational inefficiencies.
In the fourth quarter of fiscal 2018, Jack in the Box witnessed its overall revenue decline 23.5% year over year. Moreover, the company announced that it began first-quarter fiscal 2019 on a disappointing note. Comps for the first seven weeks of the fiscal first quarter decreased 1-2% due to Ribeye Burger’s dismal performance. For fiscal 2019, the company anticipates comps to be in the range of flat to up 2%.
Further, the company is facing intense competition from high-end fast food chains. While several other restaurateurs, including McDonald’s (MCD - Free Report) , have opened outlets in the emerging markets, Jack in the Box has a limited international presence. Moreover, the company is experiencing increased competitive pressure on breakfast and lunch day parts as many other restaurateurs have introduced aggressive value offers.
BJ's Restaurants has reported better-than-expected earnings in the trailing four quarters, recording positive average surprise of 33.2%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Jack in the Box Stock Gains on Alternative Strategic Plan
Jack in the Box Inc. (JACK - Free Report) announced that it is exploring a range of strategic and financing alternatives. This hamburger restaurant chain, with more than 2,000 restaurants, is looking for options that may include the sale of the company. Following the news, the company’s shares gained 2.1% on Dec 17. However, the company’s shares have declined 19.2% in a year’s time, against the industry’s growth of 7.8%.
Nevertheless, the company further added that it has not set any deadline for the completion of this process. Although there is no certainty about any potential deal, the company has started to look for potential buyers. Notably, Jack in the Box sold its subsidiary Qdoba to Apollo Global Management (APO - Free Report) in March 2018.
The Zacks Rank #5 (Strong Sell) company has been bearing the brunt of declining sales for quite some time now. Despite selling its Qdoba subsidiary, the company failed to overcome the hurdles of soft comps and operational inefficiencies.
In the fourth quarter of fiscal 2018, Jack in the Box witnessed its overall revenue decline 23.5% year over year. Moreover, the company announced that it began first-quarter fiscal 2019 on a disappointing note. Comps for the first seven weeks of the fiscal first quarter decreased 1-2% due to Ribeye Burger’s dismal performance. For fiscal 2019, the company anticipates comps to be in the range of flat to up 2%.
Further, the company is facing intense competition from high-end fast food chains. While several other restaurateurs, including McDonald’s (MCD - Free Report) , have opened outlets in the emerging markets, Jack in the Box has a limited international presence. Moreover, the company is experiencing increased competitive pressure on breakfast and lunch day parts as many other restaurateurs have introduced aggressive value offers.
Key Pick
A better-ranked stock worth considering in the same space includes BJ's Restaurants, Inc. (BJRI - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
BJ's Restaurants has reported better-than-expected earnings in the trailing four quarters, recording positive average surprise of 33.2%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>